Hinova Announces First Patient Dosed in a Phase I Clinical Tri...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
MELBOURNE, Australia, Jan. 21, 2022 /PRNewswire-Asianet/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, announced that the first patient with metastatic...
Authors: LATEST ASIANET NEWS RELEASES